Uri A Lopatin
CIK 1613259 · View on SEC EDGAR ↗
First SEC filing: July 14, 2014 · Latest: Feb. 11, 2016
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 6, 2018 | ASMB | S 10b5-1 | 336 | $40.01 | $13,443 | 613,611 Direct | -0.05% | Disposed | -92.8% (price as of 2026-08-21) |
| Sept. 5, 2018 | ASMB | S 10b5-1 | 15,204 | $40.09 | $609,528 | 613,947 Direct | -2.42% | Disposed | -92.8% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 29, 2019 | ASMB | Stock Option (right to buy) | Common Stock (27,500) | $19.69 | March 29, 2029 | 27,500 | Acquired |
| March 29, 2018 | ASMB | Stock Option (right to buy) | Common Stock (15,000) | $49.14 | March 29, 2028 | 15,000 | Acquired |
| March 29, 2017 | ASMB | Stock Option (right to buy) | Common Stock (12,500) | $25.34 | March 29, 2027 | 12,500 | Acquired |
| July 10, 2014 | ASMB | Stock Option (right to buy) | Common Stock, $0.001 par value per share | — | July 10, 2024 | 160,000 | Acquired |
| July 10, 2014 | ASMB | Stock Option (right to buy) | Common Stock, $0.001 par value per share | — | July 10, 2024 | 160,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 14, 2014 | ASMB | Common Stock | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ASMB
M.D. Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $364,167 | — | — | $224,342 | $128,700 | — | $10,769 | $728,394 |
| 2016 | $344,167 | — | — | — | $116,000 | — | — | $460,167 |
| 2015 | $319,000 | — | — | — | $95,700 | — | — | $414,700 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.